Fluorescence probe detects apoptosis and ferroptosis in tumor and rheumatoid arthritis, suggesting new imaging techniques.
Targeting mitochondria and nucleus fluorescent probes have emerged as powerful tools for monitoring cellular processes, such as apoptosis and ferroptosis. Nevertheless, only a few near-infrared (NIR) fluorescent probes have been developed for the simultaneous detection of both viscosity and DNA/RNA. Therefore, a mitochondrion- and nucleus-targeted NIR fluorescence probe (BHD) for the detection of viscosity and DNA/RNA was designed and synthesized through the condensation reaction of 1,1,2,3-Tetramethyl-1H-benzo[e]indolium hexafluorophosphate and 4-(dimethylamino)cinnamaldehyde. BHD exhibited remarkable stability under physiological pH and in the presence of biological ions. Due to its cationic structure and strong DNA/RNA binding affinity, BHD was capable of simultaneously targeting both mitochondria and the nucleus. Cellular imaging analysis showed that BHD can effectively detect apoptosis induced by hydrogen peroxide (H₂O₂) and cisplatin. Interestingly, BHD also revealed that the living cells treated with rotenone for a short duration did not undergo an apoptosis process. By monitoring the variation in fluorescence intensity, BHD can efficiently monitor ferroptosis induced by erastin and further showed that Ferrostatin-1 (Fer-1) was able to inhibit this process. Notably, in vivo imaging of viscosity fluctuations associated with tumoral ferroptosis and rheumatoid arthritis (RA) models has been successfully accomplished.
No takes yet. Share an insight, caveat, or question.
Lei et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: